Radiation-Immunotherapy combo shows promise for tough head and neck cancers
NCT ID NCT04454489
First seen Nov 19, 2025 · Last updated Jun 17, 2026 · Updated 33 times
Summary
This study tested a new approach for people with advanced or recurrent head and neck cancer that cannot be cured with standard treatments. It combined a special short-course radiation therapy (quad-shot) with immunotherapy drugs to help the immune system fight the cancer. The goal was to see if this combination could shrink tumors and be safe for patients. The study included 21 participants and measured how many had their tumors shrink or disappear.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC HEAD-AND-NECK SQUAMOUS-CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem, North Carolina, 27157, United States
Conditions
Explore the condition pages connected to this study.